GFAP and Alzheimer disease: In the present study, we further demonstrated that the astrocyte reactivity measured by plasma GFAP significantly influences the association between plasma Aβ42/Aβ40 and plasma p-Tau181 and their relations with the downstream events of AD, including AD-signature cortical tau aggregation and cortical thinning.